Translumina unveils dual-drug polymer-free coated stent in international markets

Image credit: https://translumina.com/in/

New Delhi-based Translumina has launched VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various international markets including Europe. 

VIVO ISAR is the first Dual Drug Polymer-Free Coronary Stent technology, which brings together a stent with a superior safety profile without compromising the drug release kinetics. 

VIVO ISAR is the first technology that uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenotic drug) and thus creates a polymer-free DES platform with uncompromised safety and efficacy. 

Translumina has launched VIVO ISAR in Italy & Spain and plans to roll it out in several markets across Europe, Latin America and APAC over the coming months.